Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Marceau West

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|June 22, 2021
Survival analysis using a 5-step stratified testing and amalgamation routine (5-STAR) in randomized clinical trialsDevan V Mehrotra, Rachel Marceau West
Clinical Trials (London, England)|February 2, 2024
Is inadequate risk stratification diluting hazard ratio estimates in randomized clinical trials?Devan V Mehrotra, Rachel Marceau West
Statistics in Medicine|September 21, 2020
Survival analysis using a 5-step stratified testing and amalgamation routine (5-STAR) in randomized clinical trialsDevan V Mehrotra, Rachel Marceau West
Clinical Trials (London, England)|August 9, 2024
Analysis of composite time-to-event endpoints in cardiovascular outcome trialsRachel Marceau West, Gregory Golm, Devan V Mehrotra
NPJ Genomic Medicine|November 21, 2025
Improving polygenic risk score based drug response prediction using transfer learningYoushu Cheng, Song Zhai, Wujuan Zhong, et al.
Lancet (London, England)|August 15, 2021
Voriconazole pharmacogenetics - Authors' replyJohan A Maertens, Hetty A Waskin, Rachel Marceau West, et al.
Statistics in Medicine|July 8, 2022
CAPITAL: Optimal subgroup identification via constrained policy tree searchHengrui Cai, Wenbin Lu, Rachel Marceau West, et al.
Statistics in Medicine|July 2, 2024
Exploratory subgroup identification in the heterogeneous Cox model: A relatively simple procedureLarry F León, Thomas Jemielita, Zifang Guo, et al.
Clinical Pharmacology and Therapeutics|December 10, 2021
Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir PharmacokineticsJonathan A Robbins, Karsten Menzel, Michael Lassman, et al.
Plos Computational Biology|February 20, 2019
Identifying individual risk rare variants using protein structure guided local tests (POINT)Rachel Marceau West, Wenbin Lu, Daniel M Rotroff, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|June 22, 2021
Survival analysis using a 5-step stratified testing and amalgamation routine (5-STAR) in randomized clinical trialsDevan V Mehrotra, Rachel Marceau West
Clinical Trials (London, England)|February 2, 2024
Is inadequate risk stratification diluting hazard ratio estimates in randomized clinical trials?Devan V Mehrotra, Rachel Marceau West
Statistics in Medicine|September 21, 2020
Survival analysis using a 5-step stratified testing and amalgamation routine (5-STAR) in randomized clinical trialsDevan V Mehrotra, Rachel Marceau West
Clinical Trials (London, England)|August 9, 2024
Analysis of composite time-to-event endpoints in cardiovascular outcome trialsRachel Marceau West, Gregory Golm, Devan V Mehrotra
NPJ Genomic Medicine|November 21, 2025
Improving polygenic risk score based drug response prediction using transfer learningYoushu Cheng, Song Zhai, Wujuan Zhong, et al.
Lancet (London, England)|August 15, 2021
Voriconazole pharmacogenetics - Authors' replyJohan A Maertens, Hetty A Waskin, Rachel Marceau West, et al.
Statistics in Medicine|July 8, 2022
CAPITAL: Optimal subgroup identification via constrained policy tree searchHengrui Cai, Wenbin Lu, Rachel Marceau West, et al.
Statistics in Medicine|July 2, 2024
Exploratory subgroup identification in the heterogeneous Cox model: A relatively simple procedureLarry F León, Thomas Jemielita, Zifang Guo, et al.
Clinical Pharmacology and Therapeutics|December 10, 2021
Acute and Chronic Effects of Rifampin on Letermovir Suggest Transporter Inhibition and Induction Contribute to Letermovir PharmacokineticsJonathan A Robbins, Karsten Menzel, Michael Lassman, et al.
Plos Computational Biology|February 20, 2019
Identifying individual risk rare variants using protein structure guided local tests (POINT)Rachel Marceau West, Wenbin Lu, Daniel M Rotroff, et al.
Pageof 2